BROSSARD, QUEBEC--(Marketwire - Nov. 24, 2011) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces that, on November 22nd, 2011, the Board of Directors has approved a grant of 250,000 stock options to two employees of the Corporation and 100,000 stock options to one director of the Corporation under the terms of the share stock option plan of the Corporation approved by the Shareholders in September 2008.
The exercise price of these options has been established at C$0.31 per share. Grants of stock options vest at 33.33% per year, commencing with the first anniversary of the grant. The expiry date to which these options can be exercised has been fixed to November 21, 2016.
About DIAGNOS
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.
For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
DIAGNOS Inc.
(450) 678-8882
alarente@diagnos.com
Louis Morin
Bid Capital Markets
(514) 845-1101
bidcapital@videotron.ca